protoporphyrin ix has been researched along with artemisinin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bussygina, OG; Khropov, YV; Mikhailitsyn, FS; Pyatakova, NV; Severina, IS | 1 |
| Gerhard, GS; Zhang, S | 1 |
2 other study(ies) available for protoporphyrin ix and artemisinin
| Article | Year |
|---|---|
Inhibition of nitric oxide-dependent activation of soluble guanylyl cyclase by the antimalarial drug, artemisinin.
Topics: Antimalarials; Artemisinins; Catalase; Dose-Response Relationship, Drug; Enzyme Activation; Guanylate Cyclase; Humans; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Protoporphyrins; Sesquiterpenes; Solubility; Superoxide Dismutase | 2002 |
Heme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation target.
Topics: Aminolevulinic Acid; Anti-Infective Agents; Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Evaluation, Preclinical; Heme; Humans; Iron; Models, Chemical; Protoporphyrins; Spectrophotometry; Transferrin | 2009 |